Neurobiology of Aging
Volume 31, Issue 4 , Pages 614-624 , April 2010

Memory loss caused by β-amyloid protein is rescued by a β3-adrenoceptor agonist

  • Marie E. Gibbs

      Affiliations

    • Department of Anatomy and Developmental Biology, Monash University, Clayton Campus, Wellington Road, Clayton, Victoria 3800, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 3 9905 2714; fax: +61 3 9905 8192.
    • ,
  • Danuta Maksel

      Affiliations

    • Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia
    • ,
  • Zoe Gibbs

      Affiliations

    • Department of Psychology, Monash University, Clayton, Victoria 3800, Australia
    • ,
  • Xu Hou

      Affiliations

    • Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia
    • ,
  • Roger J. Summers

      Affiliations

    • Department of Pharmacology, Monash University, Clayton, Victoria 3800, Australia
    • ,
  • David H. Small

      Affiliations

    • Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia
    • Menzies Research Institute, Hobart, Tasmania 7000, Australia

Received 30 December 2007 ,Revised 20 April 2008 ,Accepted 21 May 2008.

References 

  1. Arnsten AFT. Catecholamine modulation of prefrontal cortical cognitive function. TiCS. 1998;2:436–447
  2. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 2003;42:33–84
  3. Boothby LA, Doering PL. Vitamin C and vitamin E for Alzheimer's disease. Ann. Pharmacother. 2005;39:2073–2080
  4. Camm EJ, Harding R, Lambert GW, Gibbs ME. The role of catecholamines in memory impairment in chicks following reduced gas exchange in ovo. Neuroscience. 2004;128:545–553
  5. Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 2003;26:267–298
  6. Gainotti G, Marra C, Villa G, Parlato V, Chiarotti F. Sensitivity and specificity of some neuropsychological markers of Alzheimer dementia. Alzheimer Dis. Assoc. Disord. 1998;12:152–162
  7. German DC, Eisch AJ. Mouse models of Alzheimer's disease: insight into treatment. Rev. Neurosci. 2004;15:353–369
  8. Gibbs, M.E., 2008. Memory systems in the chick: regional and temporal control by noradrenaline. Brain Res. Bull. E-pub doi:10.1016/j.brainresbull.2008.02.021.
  9. Gibbs, M.E., Bowser, D.N., Hutchinson, D.S., Loiacono, R.E., Summers, R.J., 2008. Memory processing in the avian hippocampus involves interactions between β-adrenoceptors, glutamate receptors and metabolism. Neuropsychopharmacology. E-pub doi:10.1038/npp.2008.5.
  10. Gibbs, M.E., Hutchinson, D.S., Summers, R.J., 2007. Role of β-adrenoceptors in memory consolidation: β3-adrenoceptors act on glucose uptake and β2-adrenoceptors on glycogenolysis. Neuropsychopharmacology. E-pub doi:10.1038/sj.npp.1301629.
  11. Gibbs ME, Summers RJ. Separate roles for β2- and β3-adrenoceptors in memory consolidation. Neuroscience. 2000;95:913–922
  12. Gibbs ME, Summers RJ. Effects of glucose and 2-deoxyglucose on memory formation in the chick: interaction with β3-adrenoceptor agonists. Neuroscience. 2002;114:69–79
  13. Gibbs ME, Summers RJ. Role of adrenoceptor subtypes in memory consolidation. Prog. Neurobiol. 2002;67:345–391
  14. Gibbs ME, Summers RJ. Contrasting roles for β1. β2 and β3-adrenoceptors in memory formation in the chick. Neuroscience. 2005;131:31–42
  15. Haglund M, Sjobeck M, Englund E. Locus ceruleus degeneration is ubiquitous in Alzheimer's disease: possible implications for diagnosis and treatment. Neuropathology. 2006;26:528–532
  16. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356
  17. Hein L. Adrenoceptors and signal transduction in neurons. Cell Tissue Res. 2006;326:541–551
  18. Hertz L. Is Alzheimer's disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic and functional interactions between neurons and glial cells?. Brain Res. Rev. 1989;14:335–353
  19. Hou X, Parkington HC, Coleman HA, Mechler A, Martin LL, Aguilar MI, et al. Transthyretin oligomers induce calcium influx via voltage-gated calcium channels. J. Neurochem. 2007;100:446–457
  20. Hutchinson DS, Bengtsson T, Evans BA, Summers RJ. Mouse β3a- and β3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways. Br. J. Pharmacol. 2002;135:1903–1914
  21. Hutchinson DS, Summers RJ, Gibbs ME. β2- and β3-adrenoceptors activate glucose uptake in chick astrocytes by distinct mechanisms: a mechanism for memory enhancement?. J. Neurochem. 2007;103:997–1008
  22. Izquierdo I, Bevilaqua LR, Rossato JI, Bonini JS, Medina JH, Cammarota M. Different molecular cascades in different sites of the brain control memory consolidation. Trends Neurosci. 2006;29:496–505
  23. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 2004;13:159–170
  24. Jarrett JT, Lansbury PT. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell. 1993;73:1055–1058
  25. Jarvis ED, Gunturkun O, et al. Opinion: avian brains and a new understanding of vertebrate brain evolution. Nat. Rev. Neurosci. 2005;6:151–159
  26. Karl T, Pabst R, von Horsten S. Behavioral phenotyping of mice in pharmacological and toxicological research. Exp. Toxicol. Pathol. 2003;55:69–83
  27. Kim J, Onstead L, Rande S, Price R, Smithson L, Zwizinski C, et al. Aβ40 inhibits amyloid deposition in vivo. J. Nsci. 2007;27:627–633
  28. Klein WL, Krafft GA, Finch CE. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?. Trends Neurosci. 2001;24:219–224
  29. Knobloch M, Farinelli M, Konietzko U, Nitsch RM, Mansuy IM. Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms. J. Neurosci. 2007;27:7648–7653
  30. Koh JY, Yang LL, Cotman CW. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 1990;533:315–320
  31. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 1998;95:6448–6453
  32. Lee JL, Everitt BJ, Thomas KL. Independent cellular processes for hippocampal memory consolidation and reconsolidation. Science. 2004;304:839–843
  33. Lefkowitz RJ. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol. Sci. 2004;25:413–422
  34. Losic D, Martin LL, Aguilar MI, Small DH. Beta-amyloid fibril formation is promoted by step edges of highly oriented pyrolytic graphite. Biopolymers. 2006;84:519–526
  35. Marien MR, Colpaert FC, Rosenquist AC. Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res. Brain Res. Rev. 2004;45:38–78
  36. Matthies H. Neurobiological aspects of learning and memory. Annu. Rev. Psychol. 1989;40:381–404
  37. Mileusnic R, Lancashire C, Clark J, Rose SP. Protection against Abeta-induced memory loss by tripeptide d-Arg-l-Glu-l-Arg. Behav. Pharmacol. 2007;18:231–238
  38. Mileusnic R, Lancashire CL, Rose SP. The peptide sequence Arg-Glu-Arg, present in the amyloid precursor protein, protects against memory loss caused by A beta and acts as a cognitive enhancer. Eur. J. Neurosci. 2004;19:1933–1938
  39. Miller S, Yasuda M, Coats JK, Jones Y, Martone ME, Mayford M. Disruption of dendritic translation of CaMKIIalpha impairs stabilization of synaptic plasticity and memory consolidation. Neuron. 2002;36:507–519
  40. Morgan D. Learning and memory deficits in APP transgenic mouse models of amyloid deposition. Neurochem. Res. 2003;28:1029–1034
  41. Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature. 2006;443:768–773
  42. Prapong T, Buss J, Hsu WH, Heine P, West Greenlee H, Uemura E. Amyloid beta-peptide decreases neuronal glucose uptake despite causing increase in GLUT3 mRNA transcription and GLUT3 translocation to the plasma membrane. Exp. Neurol. 2002;174:253–258
  43. Prapong T, Uemura E, Hsu WH. G protein and cAMP-dependent protein kinase mediate amyloid beta-peptide inhibition of neuronal glucose uptake. Exp. Neurol. 2001;167:59–64
  44. Ramos BP, Arnsten AF. Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol. Ther. 2007;113:523–536
  45. Rickard NS, Poot AC, Gibbs ME, Ng KT. Both non-NMDA and NMDA glutamate receptors are necessary for memory consolidation in the day-old chick. Behav. Neural Biol. 1994;62:33–40
  46. Rose SPR. God's organism? The chick as a model system for memory studies. Learn. Mem. 2000;7:1–17
  47. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 2007;27:2866–2875
  48. Shearman MS, Ragan CI, Iversen LL. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc. Natl. Acad. Sci. U.S.A. 1994;91:1470–1474
  49. Small DH, Mok SS, Bornstein JC. Alzheimer's disease and Abeta toxicity: from top to bottom. Nat. Rev. Neurosci. 2001;2:595–598
  50. Storey E, Kinsella GJ, Slavin MJ. The neuropsychological diagnosis of Alzheimer's disease. J. Alzheimers Dis. 2001;3:261–285
  51. Storey E, Slavin MJ, Kinsella GJ. Patterns of cognitive impairment in Alzheimer's disease: assessment and differential diagnosis. Front. Biosci. 2002;7:e155–184
  52. Subramaniam R, Koppal T, Green M, Yatin S, Jordan B, Drake J, et al. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25–35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 1998;23:1403–1410
  53. Sullivan RM, Wilson DA. The locus coeruleus, norepinephrine, and memory in newborns. Brain Res. Bull. 1994;35:467–472
  54. Szot P, White SS, Greenup JL, Leverenz JB, Peskind ER, Raskind MA. Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies. J. Neurosci. 2006;26:467–478
  55. Tabet N, Birks J, Grimley Evans J. Vitamin E for Alzheimer's disease. Cochrane Database Syst. Rev. 2000;CD002854
  56. Townsend M, Cleary JP, Mehta T, Hofmeister J, Lesne S, O’Hare E, et al. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Ann. Neurol. 2006;60:668–676
  57. Townsend M, Mehta T, Selkoe DJ. Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J. Biol. Chem. 2007;
  58. Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 2006;572:477–492
  59. Troster AI, Butters N, Salmon DP, Cullum CM, Jacobs D, Brandt J, et al. The diagnostic utility of savings scores: differentiating Alzheimer's and Huntington's diseases with the logical memory and visual reproduction tests. J. Clin. Exp. Neuropsychol. 1993;15:773–788
  60. van Dooren T, Dewachter I, Borghgraef P, van Leuven F. Transgenic mouse models for APP processing and Alzheimer's disease: early and late defects. Subcell. Biochem. 2005;38:45–63
  61. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron. 2004;44:181–193
  62. Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch. Neurol. 1991;48:278–281

PII: S0197-4580(08)00171-1

doi: 10.1016/j.neurobiolaging.2008.05.018

Neurobiology of Aging
Volume 31, Issue 4 , Pages 614-624 , April 2010

Article Tools

* Image Usage & Resolution